Cardiovascular disease risk factors and cognitive impairment

The American Journal of Cardiology
David T Nash, Howard Fillit

Abstract

The role of cardiovascular disease risk factors in the occurrence and progression of cognitive impairment has been the subject of a significant number of publications but has not achieved widespread recognition among many physicians and educated laymen. It is apparent that the active treatment of certain of these cardiovascular disease risk factors is accompanied by a reduced risk for cognitive impairment. Patients with hypertension who are treated experience fewer cardiovascular disease events as well as less cognitive impairment than similar untreated patients. Patients who exercise may present with less cognitive impairment, and obesity may increase the risk for cognitive impairment. Lipid abnormalities and genetic markers are associated with an increased risk for cardiovascular disease and cognitive impairment. Autopsy studies have demonstrated a correlation between elevated levels of cholesterol and amyloid deposition in the brain. Research has demonstrated a relation between atherosclerotic obstruction lesions in the circle of Willis and dementia. Diabetes mellitus is associated with an increased risk for cardiovascular disease and cognitive impairment. A number of nonpharmacologic factors have a role in reducing the risk...Continue Reading

References

Jul 1, 1987·Journal of the History of Medicine and Allied Sciences·T G Beach
Apr 27, 1996·Lancet·I SkoogA Svanborg
Dec 10, 1997·Annals of Neurology·S KalmijnM M Breteler
May 5, 2000·Neurobiology of Aging·L J LaunerR J Havlik
Jan 10, 2001·Neurology·D KnopmanUNKNOWN Atherosclerosis Risk in Communities (ARIC) Study Investigators
Feb 15, 2001·Archives of Internal Medicine·W H BirkenhägerJ A Staessen
May 30, 2001·Neurobiology of Aging·B A in't VeldM M Breteler
Feb 13, 2003·Archives of Neurology·Martha Clare MorrisRobert S Wilson
Jul 16, 2003·Archives of Internal Medicine·Deborah GustafsonIngmar Skoog
Sep 27, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Alex E RoherThomas G Beach
Feb 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Stanley J ColcombeSteriani Elavsky
Feb 26, 2004·Lancet Neurology·Suzanne Craft, G Stennis Watson
Nov 13, 2004·JAMA : the Journal of the American Medical Association·Kristine YaffeAnne B Newman
Jan 25, 2005·Current Diabetes Reports·Lenore J Launer
Mar 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Giselle P LimGreg M Cole
May 11, 2005·Archives of Neurology·D Larry SparksChuck Ziolwolski

❮ Previous
Next ❯

Citations

May 31, 2012·European Heart Journal·Christiane E AngermannGeorg Ertl
Jun 20, 2012·Alzheimer Disease and Associated Disorders·Gustavo C RománHoward Fillit
Nov 21, 2008·The British Journal of Ophthalmology·J M CrossC Owsley
Aug 30, 2008·Srpski arhiv za celokupno lekarstvo·Dragan M Pavlović, Aleksandra M Pavlović
Jan 18, 2011·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Kerstin BettermannGregory L Burke
Dec 1, 2009·Journal of Clinical Lipidology·David T Nash
Jun 24, 2009·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Chi-Shin WuKeh-Ming Lin
Feb 5, 2008·Diabetes Research and Clinical Practice·Junko IbataKishio Nanjo
Aug 1, 2007·Journal of Clinical Lipidology·David T Nash
Oct 23, 2009·Annals of Neurology·Walter M PalmUNKNOWN Age, Gene/Environment Susceptibility-Reykjavik Study
Aug 25, 2007·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·V H Taylor, G M MacQueen
Dec 4, 2008·Molecular Nutrition & Food Research·Dilip Ghosh, Arjan Scheepens
May 19, 2012·Annals of Neurology·Olivia I OkerekeFrancine Grodstein
Mar 7, 2013·Geriatrics & Gerontology International·Yu SongYan Wu
Sep 17, 2014·British Journal of Clinical Pharmacology·Kah L GohIan J Douglas
Oct 20, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Rebecca L RuebnerSusan L Furth
Oct 10, 2006·The American Journal of Cardiology·Francesco PanzaVincenzo Solfrizzi
Jan 27, 2015·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Thomas G BeachMarwan N Sabbagh
Jul 22, 2014·Journal of Neuroscience Research·Monica CurròRiccardo Ientile
Mar 12, 2016·Journal of Aging and Health·Sreenivas P VeerankiRebeca Wong
Mar 5, 2018·Psychopharmacology·Anand M BokareYogendra Nayak
Jan 12, 2012·European Journal of Clinical Nutrition·C MaffeisS Cortese
Jan 6, 2011·Public Health Nutrition·Diane HoskingCarlene Wilson
Jan 17, 2008·Journal of Cardiopulmonary Rehabilitation and Prevention·Sebastien CarlesJean-Michel Senard
Nov 23, 2011·Pharmacological Reviews·Patrizia GazzerroMaurizio Bifulco
Dec 18, 2019·Animals : an Open Access Journal From MDPI·Tomàs CampsXavier Manteca
Apr 14, 2017·PloS One·Ting-Bin ChenPei-Ning Wang
May 3, 2018·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Ali Asghar HemmatiAkram Ahangarpour

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.